JPMORGAN CHASE & CO - CANDEL THERAPEUTICS INC ownership

CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 22 filers reported holding CANDEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$189
-19.2%
203
+9.1%
0.00%
Q2 2023$2341860.0%0.00%
Q1 2023$01860.0%0.00%
Q4 2022$0
-100.0%
186
-87.2%
0.00%
Q3 2022$5,000
+25.0%
1,458
+16.9%
0.00%
Q2 2022$4,000
-76.5%
1,247
-63.2%
0.00%
Q1 2022$17,000
-15.0%
3,387
+33.9%
0.00%
Q4 2021$20,0002,5290.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$1,780,3985.13%
Sands Capital Ventures, LLC 811,737$746,7980.22%
Empirical Asset Management, LLC 10,000$9,2000.01%
Baystate Wealth Management LLC 97,310$89,5250.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,595$123,3130.00%
FRANKLIN RESOURCES INC 1,125,000$1,046,2500.00%
OneDigital Investment Advisors LLC 25,428$23,3940.00%
WELLS FARGO & COMPANY/MN 108$990.00%
NORTHERN TRUST CORP 19,617$18,0480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CANDEL THERAPEUTICS INC shareholders